Literature DB >> 21211392

[Change of serum ACTH and cortisol levels in Alzheimer disease and mild cognition impairment].

Jian-kang Lei1.   

Abstract

OBJECTIVE: To characterize the response of adrenocorticotropic hormone (ACTH) and cortisol in the patients with Alzheimer disease (AD) and those with mild cognition impairment (MCI).
METHODS: The AD or MCI patients at our department from July 5, 2007 to August 31, 2009 were enrolled. The levels of 8am serum ACTH and cortisol were measured by chemiluminescence in 54 AD patients, 41 MCI patients and 42 age-matched controls.
RESULTS: The serum ACTH values in 3 groups were (16 ± 5), (16 ± 5) and (17 ± 4) ng/L respectively. The serum ACTH values had insignificant changes in 3 groups (P > 0.05). The serum cortisol values were (595 ± 58), (568 ± 70) and (410 ± 81) nmol/L in 3 groups respectively. And the serum cortisol values significantly increased in AD and MCI groups (P < 0.01). The levels of serum cortisol in MCI group were lower than those in AD group. But there was no significant difference (P > 0.05). Through an analysis of rank correlation, the severity of AD had a positive correlation with serum concentration of cortisol (P < 0.05); there was a negative correlation between the serum level of cortisol and the scores of MMSE in AD patients (P < 0.05). There was no significant change of serum level of cortisol for different genders in 3 groups (P > 0.05).
CONCLUSION: The level of serum ACTH has no significant change. A high level of serum cortisol is observed in AD and MCI groups. There is a positive correlation between serum level of cortisol and the severity of AD and a negative correlation between serum level of cortisol and the scores.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21211392

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Za Zhi        ISSN: 0376-2491


  3 in total

1.  Combined Plasma and Cerebrospinal Fluid Signature for the Prediction of Midterm Progression From Mild Cognitive Impairment to Alzheimer Disease.

Authors:  Benoit Lehallier; Laurent Essioux; Javier Gayan; Roxana Alexandridis; Tania Nikolcheva; Tony Wyss-Coray; Markus Britschgi
Journal:  JAMA Neurol       Date:  2015-12-14       Impact factor: 18.302

2.  Heme oxygenase-1 posttranslational modifications in the brain of subjects with Alzheimer disease and mild cognitive impairment.

Authors:  Eugenio Barone; Fabio Di Domenico; Rukhsana Sultana; Raffaella Coccia; Cesare Mancuso; Marzia Perluigi; D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2012-04-17       Impact factor: 7.376

3.  Influence of genetic variation on plasma protein levels in older adults using a multi-analyte panel.

Authors:  Sungeun Kim; Shanker Swaminathan; Mark Inlow; Shannon L Risacher; Kwangsik Nho; Li Shen; Tatiana M Foroud; Ronald C Petersen; Paul S Aisen; Holly Soares; Jon B Toledo; Leslie M Shaw; John Q Trojanowski; Michael W Weiner; Brenna C McDonald; Martin R Farlow; Bernardino Ghetti; Andrew J Saykin
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.